27 stories from 12 sources
Supporting Articles
Federal Trade Commission investigators and state authorities are examining Epic Systems' business practices, according to people contacted by investigators. The inquiry concerns alleged anti-competitive conduct, though no findings have been established.
5:00 PMStat News
New York City confirmed two additional deaths in the Upper East Side Legionnaires' disease outbreak, bringing the total to nine. The toll now exceeds that of last summer's Harlem outbreak.
4:47 PMGothamist
The FDA approved Bristol Myers Squibb’s oral treatment for advanced multiple myeloma, introducing a new class of medicine for the blood cancer.
10:00 AMStat News
The FDA approved Bristol Myers Squibb’s treatment for advanced multiple myeloma, marking the first approval of a new drug class for the disease.
8:03 AMStat News
A newly finalized CMS rule restricting gender-affirming care for transgender young people may face a stronger legal footing than earlier Trump administration efforts to end such care.
4:30 AMStat News
A U.S. appeals court ruled for Gilead Sciences in a case involving alternative funding programs that import the company's medicines from overseas. The ruling blocks those companies from continuing that practice.
12:27 PMCNBC
Major pharmacy benefit managers have agreed to display drug prices through TrumpRx, expanding the administration's effort to make prescription costs more visible to patients. The move follows broader biotech developments, including an accelerated approval for Bristol's Zenbexus and a UK patent ruling favoring Novartis's Entresto.
11:55 AMStat News
Patients who cannot secure coverage for needed medical care are turning to social-media platforms to publicize their cases and seek help. Their appeals reflect how difficult formal insurance appeals and authorization processes can be to navigate.
10:13 AMMarketWatchSummary
Federal Trade Commission investigators and state authorities are examining Epic Systems' business practices, according to people contacted by investigators. The inquiry concerns alleged anti-competitive conduct, though no findings have been established.
Regulatory scrutiny could challenge how Epic uses its dominant position in electronic health records and
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A major antitrust investigation could reshape competition and data access across the health IT market.
Summary
New York City confirmed two additional deaths in the Upper East Side Legionnaires' disease outbreak, bringing the total to nine. The toll now exceeds that of last summer's Harlem outbreak.
The outbreak is now deadlier than the city's previous major Legionnaires' cluster, increasing pressure on
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The rising death toll signals a larger public health failure than initially understood and raises questions about the city's response.
Summary
The FDA approved Bristol Myers Squibb’s oral treatment for advanced multiple myeloma, introducing a new class of medicine for the blood cancer.
The approval expands treatment options for patients with advanced disease and gives Bristol an early
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A new drug class could reshape treatment sequencing in multiple myeloma if it delivers meaningful benefits over existing options.
Summary
The FDA approved Bristol Myers Squibb’s treatment for advanced multiple myeloma, marking the first approval of a new drug class for the disease.
The decision gives physicians a new mechanism for treating advanced myeloma and gives Bristol a
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The approval creates a new treatment option for a serious blood cancer and could alter how later-line patients are treated.
Summary
A newly finalized CMS rule restricting gender-affirming care for transgender young people may face a stronger legal footing than earlier Trump administration efforts to end such care.
The key shift is that CMS has now embedded the policy in a formal rule,
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The rule could reshape access to care for transgender minors and establish a more durable model for federal restrictions.
Summary
A U.S. appeals court ruled for Gilead Sciences in a case involving alternative funding programs that import the company's medicines from overseas. The ruling blocks those companies from continuing that practice.
The decision removes a low-cost sourcing strategy used by alternative funding programs to reduce medication
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The ruling could raise drug costs for employers and patients using alternative funding programs.
Summary
Major pharmacy benefit managers have agreed to display drug prices through TrumpRx, expanding the administration's effort to make prescription costs more visible to patients. The move follows broader biotech developments, including an accelerated approval for Bristol's Zenbexus and a UK patent ruling favoring Novartis's Entresto.
The agreement gives TrumpRx access to pricing information controlled by the intermediaries that negotiate drug
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Price visibility could improve comparison shopping, but it will matter only if the displayed figures translate into lower patient costs.
Summary
Patients who cannot secure coverage for needed medical care are turning to social-media platforms to publicize their cases and seek help. Their appeals reflect how difficult formal insurance appeals and authorization processes can be to navigate.
Public pressure has become an informal escalation route for patients who cannot get timely decisions
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
When social media becomes a practical route to coverage, it exposes a failure in the ordinary mechanisms meant to resolve medical-necessity disputes.
A curated list of other prominent stories from this day.
Public anger toward UnitedHealth and other insurers has continued after the killing of UnitedHealthcare executive Brian Thompson. Rising premiums and medical bills have intensified dissatisfaction with health coverage.
5:02 PMNYT New York
Scientists in Brazil are producing millions of mosquitoes in a specialized factory as part of an effort to reduce the spread of deadly tropical diseases. The program presents mosquito production as a public-health tool for a warmer world.
2:36 PMThe New York Times
The American Academy of Pediatrics president describes how pediatricians are responding to fearmongering about vaccines from federal leaders. The piece focuses on the challenge of advising parents while public health messaging becomes more politically charged.
2:34 PMStat News
New Jersey reported its first Zika case since 2020 in a Middlesex County resident, according to state health officials. Zika usually causes mild illness but poses serious risks during pregnancy.
12:23 PMGothamist
The roundup tracks recent hires, departures, promotions and transfers across the pharmaceutical industry. It provides a snapshot of changing leadership and personnel across the sector.
12:20 PMStat News
France's highest court upheld the country's assisted-dying law while rejecting a ban on social media access for teenagers. The rulings preserve one of President Emmanuel Macron's priorities but block the other.
11:52 AMAl Jazeera
A household is weighing whether a $42,000 bonus could raise its income enough to reduce or eliminate its Affordable Care Act subsidy. The financial pressure has led to advice to return the bonus and borrow against home equity.
12:00 PMMarketWatch
The article argues that prescription drugs remain unaffordable because manufacturers largely control how prices are justified against a medicine's value. It calls for a pricing framework that gives patients and payers more influence over those calculations.
11:07 AMMarketWatch
Capricor Therapeutics shares surged after the FDA agreed to review new data on its experimental Duchenne muscular dystrophy treatment. The 24-month data will focus on upper-limb muscle function as the company limits launch spending while awaiting regulatory clarity.
10:24 AMEconomic Times
Brad Pitt's disclosure that he has resumed drinking has renewed debate over whether people who once drank dangerously can later drink moderately. Experts say a return to drinking is not inherently unsafe, but the risk depends on the individual's history and current behavior.
9:39 AMNew York Times Arts
A laboratory that clashed with regulators over impurities in widely used medicines is suing the U.S. Pharmacopeia, alleging that the standards-setting group made false and misleading statements about its testing methods.
9:23 AMStat News
An analysis of more than 480,000 people found that regular stair climbing was associated with a 39% lower risk of cardiovascular death and a 24% lower risk of death from any cause. Stair users also had lower rates of heart attack, stroke, and heart failure.
8:35 AMScienceDaily
In a study of more than 21,000 participants, women who used estrogen-only hormone therapy had lower rates of dementia and fewer Alzheimer’s-related brain changes at autopsy. They also showed less evidence of amyloid buildup on biomarker testing.
7:19 AMScienceDailyFrench neurotechnology startup Robeauté is developing rice-sized microrobots to deliver drugs and other therapies to hard-to-reach areas of the brain. CEO Joana Cartocci says the company is targeting first-in-human studies in 2027 and a commercial launch in the early 2030s.
6:12 AMBloomberg Markets
Rep. Alexandria Ocasio-Cortez is freezing her eggs, bringing wider attention to the high cost of fertility preservation. Proposed legislation in Albany would require insurers to cover the procedure.
6:00 AMGothamist
Two years after federal rules loosened methadone dispensing requirements, some opioid treatment clinics have adopted more flexible practices, while others remain largely unchanged.
4:30 AMStat News
Kyle Vanelli argues that U.S. and U.K. health systems increasingly use medical institutions to address social problems that medicine cannot solve on its own. That reliance shifts the costs of housing, poverty, and other social failures onto clinics and hospitals.
4:30 AMStat News
Former boxer Prichard Colon has died after suffering severe neurological damage during a 2015 bout. The injury required emergency surgery and led to a 221-day coma.
3:11 AMAl Jazeera
The Marcus Foundation is donating nearly $30 million to stem cell research focused on repairing damage caused by heart attacks. The gift adds to the foundation’s decades-long record of major medical research donations.
3:00 AMFortuneSummary
Public anger toward UnitedHealth and other insurers has continued after the killing of UnitedHealthcare executive Brian Thompson. Rising premiums and medical bills have intensified dissatisfaction with health coverage.
The persistence of anger shows that the killing did not resolve the underlying conflict over
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Sustained public distrust could reshape the political environment for health insurer regulation.
Summary
Scientists in Brazil are producing millions of mosquitoes in a specialized factory as part of an effort to reduce the spread of deadly tropical diseases. The program presents mosquito production as a public-health tool for a warmer world.
The approach treats the disease vector itself as an intervention target rather than relying only
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Brazil is testing whether industrial-scale mosquito control can keep pace with the growing health threat created by climate change.
Summary
The American Academy of Pediatrics president describes how pediatricians are responding to fearmongering about vaccines from federal leaders. The piece focuses on the challenge of advising parents while public health messaging becomes more politically charged.
The immediate shift is a more difficult communication environment for clinicians, who must counter misinformation
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Political attacks on vaccines can translate directly into lower uptake and greater risk of preventable disease.
Summary
New Jersey reported its first Zika case since 2020 in a Middlesex County resident, according to state health officials. Zika usually causes mild illness but poses serious risks during pregnancy.
The case revives local attention to a mosquito-borne virus that can cause severe fetal complications
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A single case matters because Zika's greatest health risks fall on pregnancies, not typically on infected adults.
Summary
The roundup tracks recent hires, departures, promotions and transfers across the pharmaceutical industry. It provides a snapshot of changing leadership and personnel across the sector.
Executive movement can signal shifts in companies' strategic priorities, particularly when leadership changes cluster around
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Leadership turnover can reveal where drugmakers are changing strategy before those changes appear in results.
Summary
France's highest court upheld the country's assisted-dying law while rejecting a ban on social media access for teenagers. The rulings preserve one of President Emmanuel Macron's priorities but block the other.
The court's decisions leave France's assisted-dying framework in place while requiring lawmakers to reconsider how
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The rulings draw a sharp legal line between protecting individual end-of-life choices and restricting teenagers' digital access.
Summary
A household is weighing whether a $42,000 bonus could raise its income enough to reduce or eliminate its Affordable Care Act subsidy. The financial pressure has led to advice to return the bonus and borrow against home equity.
The bonus may create a tax and insurance-cost problem because ACA subsidy eligibility depends on
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
ACA subsidies can turn irregular income into a major insurance liability, making tax planning part of healthcare planning.
Summary
The article argues that prescription drugs remain unaffordable because manufacturers largely control how prices are justified against a medicine's value. It calls for a pricing framework that gives patients and payers more influence over those calculations.
The core problem is a power imbalance: drug companies can set prices while insurers, employers,
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Drug affordability will not improve if the companies setting prices also define what their products are worth.
Summary
Capricor Therapeutics shares surged after the FDA agreed to review new data on its experimental Duchenne muscular dystrophy treatment. The 24-month data will focus on upper-limb muscle function as the company limits launch spending while awaiting regulatory clarity.
The FDA’s willingness to review additional data reopens a regulatory path after the therapy suffered
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The review could determine whether Capricor’s Duchenne program survives as a commercial opportunity or moves toward another regulatory setback.
Summary
Brad Pitt's disclosure that he has resumed drinking has renewed debate over whether people who once drank dangerously can later drink moderately. Experts say a return to drinking is not inherently unsafe, but the risk depends on the individual's history and current behavior.
The key point is that sobriety does not produce a single medically correct outcome for
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The debate affects how people with alcohol-use histories assess relapse risk and seek care, especially when public examples blur individual medical differences.
Summary
A laboratory that clashed with regulators over impurities in widely used medicines is suing the U.S. Pharmacopeia, alleging that the standards-setting group made false and misleading statements about its testing methods.
The lawsuit escalates a dispute over which testing methods should govern drug impurity assessments and
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A legal fight over testing standards could influence how regulators and drugmakers identify and manage impurities across widely used medicines.
Summary
An analysis of more than 480,000 people found that regular stair climbing was associated with a 39% lower risk of cardiovascular death and a 24% lower risk of death from any cause. Stair users also had lower rates of heart attack, stroke, and heart failure.
The size of the association makes everyday activity look like a meaningful cardiovascular intervention, especially
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Small, accessible changes in daily movement may offer a low-cost way to improve cardiovascular health.
Summary
In a study of more than 21,000 participants, women who used estrogen-only hormone therapy had lower rates of dementia and fewer Alzheimer’s-related brain changes at autopsy. They also showed less evidence of amyloid buildup on biomarker testing.
The findings strengthen the case for investigating estrogen’s possible role in brain aging, but they
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The study could reshape research into sex-specific Alzheimer’s risks without yet changing hormone-therapy guidance.
Summary
French neurotechnology startup Robeauté is developing rice-sized microrobots to deliver drugs and other therapies to hard-to-reach areas of the brain. CEO Joana Cartocci says the company is targeting first-in-human studies in 2027 and a commercial launch in the early 2030s.
Robeauté is moving its technology from an engineering proposition toward a clinical development timeline, but
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The company is pursuing a potentially new way to overcome one of neurology's central treatment barriers: delivering therapies precisely inside the brain.
Summary
Rep. Alexandria Ocasio-Cortez is freezing her eggs, bringing wider attention to the high cost of fertility preservation. Proposed legislation in Albany would require insurers to cover the procedure.
The policy debate is shifting from personal choice to insurance access and affordability. If lawmakers
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
New York could make fertility preservation a covered health benefit rather than a service available mainly to people who can afford it.
Summary
Two years after federal rules loosened methadone dispensing requirements, some opioid treatment clinics have adopted more flexible practices, while others remain largely unchanged.
The regulatory change has not produced uniform reform. Patients still experience access based heavily on
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Methadone policy only improves care if clinics convert formal flexibility into easier, more patient-centered access.
Summary
Kyle Vanelli argues that U.S. and U.K. health systems increasingly use medical institutions to address social problems that medicine cannot solve on its own. That reliance shifts the costs of housing, poverty, and other social failures onto clinics and hospitals.
The central problem is not simply rising demand but a mismatch between the causes of
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Health systems cannot contain spending or improve outcomes if they remain the default response to unmet social needs.
Summary
Former boxer Prichard Colon has died after suffering severe neurological damage during a 2015 bout. The injury required emergency surgery and led to a 221-day coma.
Colon’s death underscores that traumatic brain injuries in boxing can impose permanent consequences long after
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The case highlights the lasting medical and regulatory costs of repeated head trauma in combat sports.
Summary
The Marcus Foundation is donating nearly $30 million to stem cell research focused on repairing damage caused by heart attacks. The gift adds to the foundation’s decades-long record of major medical research donations.
The funding gives a high-risk area of cardiovascular research a substantial private boost, but it
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A large private investment could accelerate research into treatments that restore heart function after heart attacks.
Make it yours
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!